GW&K Investment Management’s Bio-Rad Laboratories Class A BIO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$35.5M Buy
147,213
+3,334
+2% +$805K 0.32% 125
2025
Q1
$35M Sell
143,879
-1,565
-1% -$381K 0.32% 124
2024
Q4
$47.8M Buy
145,444
+212
+0.1% +$69.6K 0.41% 89
2024
Q3
$48.6M Buy
145,232
+4,391
+3% +$1.47M 0.42% 89
2024
Q2
$38.5M Buy
140,841
+2,955
+2% +$807K 0.35% 113
2024
Q1
$47.7M Buy
137,886
+93
+0.1% +$32.2K 0.42% 94
2023
Q4
$44.5M Sell
137,793
-6,921
-5% -$2.23M 0.41% 93
2023
Q3
$51.9M Sell
144,714
-205
-0.1% -$73.5K 0.52% 69
2023
Q2
$54.9M Buy
144,919
+24,946
+21% +$9.46M 0.52% 67
2023
Q1
$57.5M Buy
119,973
+1,727
+1% +$827K 0.56% 63
2022
Q4
$49.7M Buy
118,246
+32,940
+39% +$13.9M 0.5% 75
2022
Q3
$35.6M Buy
85,306
+12,447
+17% +$5.19M 0.39% 110
2022
Q2
$36.1M Sell
72,859
-8,852
-11% -$4.38M 0.39% 111
2022
Q1
$46M Sell
81,711
-24,026
-23% -$13.5M 0.41% 106
2021
Q4
$79.9M Sell
105,737
-13,012
-11% -$9.83M 0.67% 39
2021
Q3
$88.6M Sell
118,749
-1,194
-1% -$891K 0.79% 22
2021
Q2
$77.3M Buy
119,943
+1,820
+2% +$1.17M 0.67% 32
2021
Q1
$67.5M Buy
118,123
+26,568
+29% +$15.2M 0.62% 37
2020
Q4
$53.4M Buy
91,555
+38
+0% +$22.2K 0.56% 43
2020
Q3
$47.2M Sell
91,517
-5,422
-6% -$2.79M 0.62% 38
2020
Q2
$43.8M Sell
96,939
-2,531
-3% -$1.14M 0.61% 45
2020
Q1
$34.9M Buy
99,470
+5,721
+6% +$2.01M 0.61% 45
2019
Q4
$34.7M Sell
93,749
-3,173
-3% -$1.17M 0.46% 78
2019
Q3
$32.3M Buy
96,922
+9,696
+11% +$3.23M 0.45% 86
2019
Q2
$27.3M Sell
87,226
-1,718
-2% -$537K 0.41% 93
2019
Q1
$27.2M Buy
88,944
+21,395
+32% +$6.54M 0.44% 93
2018
Q4
$15.7M Buy
67,549
+806
+1% +$187K 0.31% 143
2018
Q3
$20.9M Buy
+66,743
New +$20.9M 0.34% 137